The acquisition of Laboratoire Greenpharma marks a strategic step forward in Sweetch’s ambition to build a science-led, future-ready innovation platform for the cosmetic industry.WHO: Orléans-based Laboratoire Greenpharma was founded in 2000 and is widely recognized for its expertise in natural active ingredients, phytochemistry, and green extraction technologies.Created in 2024 by Ekkio Capital, Sweetch is a beauty ingredient company focusing on natural and sustainable technologies. The initial Sweetch portfolio was created with the acquisition of three market-leading natural ingredients companies: Gobiotics, Creathes, and CreaChem.WHY: Its deep R&D capabilities and scientific infrastructure perfectly complement Sweetch’s existing strengths in microbiome technologies, delivery systems, and sustainable formulation. By joining forces, they strengthen their ability to support cosmetic brands across the full innovation journey, from ingredient discovery to objectivated performance and validated claims.IN THEIR OWN WORDS: Cyril Gallardo, CEO of Sweetch, said, “The acquisition of Laboratoire Greenpharma significantly strengthens Sweetch’s position as a leader in natural, sustainable cosmetic ingredients. In particular, it completes the active ingredients portfolio with objectivated extracts and conscious sourcing, solidifying our standing with key players in the beauty industry.”Philippe Bernard, CEO of Laboratoire Greenpharma, shared, “The values of both companies are aligned in terms of human and scientific values. We have a complementary catalogue considering products and services. That is why synergies will be present at different levels.